OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
The cortical origin and initial spread of medial temporal tauopathy in Alzheimer’s disease assessed with positron emission tomography
Justin S. Sanchez, J. Alex Becker, Heidi I.L. Jacobs, et al.
Science Translational Medicine (2021) Vol. 13, Iss. 577
Open Access | Times Cited: 165
Justin S. Sanchez, J. Alex Becker, Heidi I.L. Jacobs, et al.
Science Translational Medicine (2021) Vol. 13, Iss. 577
Open Access | Times Cited: 165
Showing 1-25 of 165 citing articles:
Biomarkers for neurodegenerative diseases
Oskar Hansson
Nature Medicine (2021) Vol. 27, Iss. 6, pp. 954-963
Open Access | Times Cited: 721
Oskar Hansson
Nature Medicine (2021) Vol. 27, Iss. 6, pp. 954-963
Open Access | Times Cited: 721
The amyloid hypothesis in Alzheimer disease: new insights from new therapeutics
Eric Karran, Bart De Strooper
Nature Reviews Drug Discovery (2022) Vol. 21, Iss. 4, pp. 306-318
Open Access | Times Cited: 485
Eric Karran, Bart De Strooper
Nature Reviews Drug Discovery (2022) Vol. 21, Iss. 4, pp. 306-318
Open Access | Times Cited: 485
Revised criteria for diagnosis and staging of Alzheimer's disease: Alzheimer's Association Workgroup
Clifford R. Jack, J. Scott Andrews, Thomas G. Beach, et al.
Alzheimer s & Dementia (2024) Vol. 20, Iss. 8, pp. 5143-5169
Open Access | Times Cited: 475
Clifford R. Jack, J. Scott Andrews, Thomas G. Beach, et al.
Alzheimer s & Dementia (2024) Vol. 20, Iss. 8, pp. 5143-5169
Open Access | Times Cited: 475
Microglial activation and tau propagate jointly across Braak stages
Tharick A. Pascoal, Andréa Lessa Benedet, Nicholas J. Ashton, et al.
Nature Medicine (2021) Vol. 27, Iss. 9, pp. 1592-1599
Open Access | Times Cited: 345
Tharick A. Pascoal, Andréa Lessa Benedet, Nicholas J. Ashton, et al.
Nature Medicine (2021) Vol. 27, Iss. 9, pp. 1592-1599
Open Access | Times Cited: 345
Tau biomarkers in Alzheimer's disease: towards implementation in clinical practice and trials
Rik Ossenkoppele, Rik van der Kant, Oskar Hansson
The Lancet Neurology (2022) Vol. 21, Iss. 8, pp. 726-734
Open Access | Times Cited: 279
Rik Ossenkoppele, Rik van der Kant, Oskar Hansson
The Lancet Neurology (2022) Vol. 21, Iss. 8, pp. 726-734
Open Access | Times Cited: 279
Biomarkers of aging
Hainan Bao, Jiani Cao, Mengting Chen, et al.
Science China Life Sciences (2023) Vol. 66, Iss. 5, pp. 893-1066
Open Access | Times Cited: 197
Hainan Bao, Jiani Cao, Mengting Chen, et al.
Science China Life Sciences (2023) Vol. 66, Iss. 5, pp. 893-1066
Open Access | Times Cited: 197
In vivo and neuropathology data support locus coeruleus integrity as indicator of Alzheimer’s disease pathology and cognitive decline
Heidi I.L. Jacobs, J. Alex Becker, Kenneth K. Kwong, et al.
Science Translational Medicine (2021) Vol. 13, Iss. 612
Open Access | Times Cited: 171
Heidi I.L. Jacobs, J. Alex Becker, Kenneth K. Kwong, et al.
Science Translational Medicine (2021) Vol. 13, Iss. 612
Open Access | Times Cited: 171
Biomarker modeling of Alzheimer’s disease using PET-based Braak staging
Joseph Therriault, Tharick A. Pascoal, Firoza Z Lussier, et al.
Nature Aging (2022) Vol. 2, Iss. 6, pp. 526-535
Open Access | Times Cited: 170
Joseph Therriault, Tharick A. Pascoal, Firoza Z Lussier, et al.
Nature Aging (2022) Vol. 2, Iss. 6, pp. 526-535
Open Access | Times Cited: 170
APOE in the bullseye of neurodegenerative diseases: impact of the APOE genotype in Alzheimer’s disease pathology and brain diseases
Rosalía Fernández‐Calle, Sabine C. Konings, Javier Frontiñán-Rubio, et al.
Molecular Neurodegeneration (2022) Vol. 17, Iss. 1
Open Access | Times Cited: 140
Rosalía Fernández‐Calle, Sabine C. Konings, Javier Frontiñán-Rubio, et al.
Molecular Neurodegeneration (2022) Vol. 17, Iss. 1
Open Access | Times Cited: 140
Regional Aβ-tau interactions promote onset and acceleration of Alzheimer’s disease tau spreading
Wha Jin Lee, Jesse A. Brown, Hye Ryun Kim, et al.
Neuron (2022) Vol. 110, Iss. 12, pp. 1932-1943.e5
Open Access | Times Cited: 121
Wha Jin Lee, Jesse A. Brown, Hye Ryun Kim, et al.
Neuron (2022) Vol. 110, Iss. 12, pp. 1932-1943.e5
Open Access | Times Cited: 121
Amyloid-associated increases in soluble tau relate to tau aggregation rates and cognitive decline in early Alzheimer’s disease
Alexa Pichet Binette, Nicolai Franzmeier, Nicola Spotorno, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 85
Alexa Pichet Binette, Nicolai Franzmeier, Nicola Spotorno, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 85
Predicting amyloid PET and tau PET stages with plasma biomarkers
Clifford R. Jack, Heather J. Wiste, Alicia Algeciras‐Schimnich, et al.
Brain (2023) Vol. 146, Iss. 5, pp. 2029-2044
Open Access | Times Cited: 75
Clifford R. Jack, Heather J. Wiste, Alicia Algeciras‐Schimnich, et al.
Brain (2023) Vol. 146, Iss. 5, pp. 2029-2044
Open Access | Times Cited: 75
Accelerating Alzheimer’s therapeutic development: The past and future of clinical trials
Adam L. Boxer, Reisa A. Sperling
Cell (2023) Vol. 186, Iss. 22, pp. 4757-4772
Open Access | Times Cited: 75
Adam L. Boxer, Reisa A. Sperling
Cell (2023) Vol. 186, Iss. 22, pp. 4757-4772
Open Access | Times Cited: 75
Integrated multimodal cell atlas of Alzheimer’s disease
Mariano I. Gabitto, Kyle J. Travaglini, Victoria M. Rachleff, et al.
Nature Neuroscience (2024)
Open Access | Times Cited: 54
Mariano I. Gabitto, Kyle J. Travaglini, Victoria M. Rachleff, et al.
Nature Neuroscience (2024)
Open Access | Times Cited: 54
Randomized Phase II Study of the Safety and Efficacy of Semorinemab in Participants With Mild-to-Moderate Alzheimer Disease: Lauriet
Cecília Monteiro, Balázs I. Tóth, Flávia Brunstein, et al.
Neurology (2023) Vol. 101, Iss. 14
Open Access | Times Cited: 45
Cecília Monteiro, Balázs I. Tóth, Flávia Brunstein, et al.
Neurology (2023) Vol. 101, Iss. 14
Open Access | Times Cited: 45
Amyloid induced hyperexcitability in default mode network drives medial temporal hyperactivity and early tau accumulation
Joseph Giorgio, Jenna N. Adams, Anne Maaß, et al.
Neuron (2023) Vol. 112, Iss. 4, pp. 676-686.e4
Open Access | Times Cited: 45
Joseph Giorgio, Jenna N. Adams, Anne Maaß, et al.
Neuron (2023) Vol. 112, Iss. 4, pp. 676-686.e4
Open Access | Times Cited: 45
Neuropathogenesis-on-chips for neurodegenerative diseases
Sarnai Amartumur, Huong Mai Nguyen, Thuy Huynh, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 26
Sarnai Amartumur, Huong Mai Nguyen, Thuy Huynh, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 26
Updated appropriate use criteria for amyloid and tau PET: A report from the Alzheimer's Association and Society for Nuclear Medicine and Molecular Imaging Workgroup
Gil D. Rabinovici, D. S. Knopman, Javier Arbizu, et al.
Alzheimer s & Dementia (2025)
Open Access | Times Cited: 8
Gil D. Rabinovici, D. S. Knopman, Javier Arbizu, et al.
Alzheimer s & Dementia (2025)
Open Access | Times Cited: 8
Updated Appropriate Use Criteria for Amyloid and Tau PET: A Report from the Alzheimer’s Association and Society for Nuclear Medicine and Molecular Imaging Workgroup
Gil D. Rabinovici, D. S. Knopman, Javier Arbizu, et al.
Journal of Nuclear Medicine (2025), pp. jnumed.124.268756-jnumed.124.268756
Closed Access | Times Cited: 2
Gil D. Rabinovici, D. S. Knopman, Javier Arbizu, et al.
Journal of Nuclear Medicine (2025), pp. jnumed.124.268756-jnumed.124.268756
Closed Access | Times Cited: 2
Biomarker-Based Prediction of Longitudinal Tau Positron Emission Tomography in Alzheimer Disease
Antoine Leuzy, Ruben Smith, Nicholas Cullen, et al.
JAMA Neurology (2021) Vol. 79, Iss. 2, pp. 149-149
Open Access | Times Cited: 102
Antoine Leuzy, Ruben Smith, Nicholas Cullen, et al.
JAMA Neurology (2021) Vol. 79, Iss. 2, pp. 149-149
Open Access | Times Cited: 102
In vivo rate-determining steps of tau seed accumulation in Alzheimer’s disease
Georg Meisl, Eric Hidari, Kieren Allinson, et al.
Science Advances (2021) Vol. 7, Iss. 44
Open Access | Times Cited: 99
Georg Meisl, Eric Hidari, Kieren Allinson, et al.
Science Advances (2021) Vol. 7, Iss. 44
Open Access | Times Cited: 99
Treatments for Alzheimer's disease emerge
Dennis J. Selkoe
Science (2021) Vol. 373, Iss. 6555, pp. 624-626
Closed Access | Times Cited: 94
Dennis J. Selkoe
Science (2021) Vol. 373, Iss. 6555, pp. 624-626
Closed Access | Times Cited: 94
Distinct tau neuropathology and cellular profiles of an APOE3 Christchurch homozygote protected against autosomal dominant Alzheimer’s dementia
Diego Sepúlveda‐Falla, Justin S. Sanchez, Maria Camila Almeida, et al.
Acta Neuropathologica (2022) Vol. 144, Iss. 3, pp. 589-601
Open Access | Times Cited: 63
Diego Sepúlveda‐Falla, Justin S. Sanchez, Maria Camila Almeida, et al.
Acta Neuropathologica (2022) Vol. 144, Iss. 3, pp. 589-601
Open Access | Times Cited: 63
Menopause Status Moderates Sex Differences in Tau Burden: A Framingham PET Study
Rachel F. Buckley, Adrienne O’Donnell, Emer R. McGrath, et al.
Annals of Neurology (2022) Vol. 92, Iss. 1, pp. 11-22
Open Access | Times Cited: 60
Rachel F. Buckley, Adrienne O’Donnell, Emer R. McGrath, et al.
Annals of Neurology (2022) Vol. 92, Iss. 1, pp. 11-22
Open Access | Times Cited: 60
Current directions in tau research: Highlights from Tau 2020
Claire E. Sexton, Heather M. Snyder, Dirk Beher, et al.
Alzheimer s & Dementia (2021) Vol. 18, Iss. 5, pp. 988-1007
Open Access | Times Cited: 59
Claire E. Sexton, Heather M. Snyder, Dirk Beher, et al.
Alzheimer s & Dementia (2021) Vol. 18, Iss. 5, pp. 988-1007
Open Access | Times Cited: 59
